Clinical Trial Update: Fibrinogen Concentrate in Isolated Traumatic Brain Injury [Phase 1, Phase 2]

View source ↗

Summary

Early-stage clinical trial update evaluating fibrinogen concentrate for traumatic brain injury with hemorrhage ongoing in Phase 1/Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• Fibrinogen concentrate (Fibrinogen concentrate)

Snippet

Sponsor: Leila Dehghani | Conditions: Traumatic Brain Injury, Hemorrhage | Phase 1, Phase 2 | Status: UNKNOWN